What is the pathophysiology of hypertrophic obstructive cardiomyopathy and its implications for anesthesia management?

Hypertrophic Obstructive Cardiomyopathy: Pathophysiology and Anesthesia Implications

Core Pathophysiology

Hypertrophic obstructive cardiomyopathy (HOCM) is a genetic disorder characterized by asymmetric left ventricular hypertrophy, dynamic left ventricular outflow tract (LVOT) obstruction, and diastolic dysfunction that creates a lethal triad of risks during anesthesia: hypotension from obstruction, myocardial ischemia, and arrhythmias. 1, 2

The fundamental pathophysiologic mechanisms include:

• Structural abnormalities: Asymmetric septal hypertrophy (typically interventricular septum), systolic anterior motion (SAM) of elongated mitral valve leaflets, and displaced or hypertrophied papillary muscles create dynamic LVOT obstruction 2

• Cellular dysfunction: Hypercontractility from increased actin-myosin cross-bridges, myocyte disarray, interstitial fibrosis, and coronary microvascular dysfunction lead to impaired myocardial relaxation, ischemia, and arrhythmogenesis 2, 3

• Hemodynamic consequences: Approximately 70% of patients develop resting or provocable LVOT obstruction, which is the most common cause of heart failure in this population 1

• Diastolic dysfunction: Left ventricular hypertrophy and decreased compliance impair ventricular filling, making these patients critically dependent on adequate preload and atrial contraction 4

Critical Anesthesia Implications

Absolute Contraindications During Anesthesia

Factors that aggravate or trigger dynamic LVOT obstruction—including positive inotropic agents, tachycardia, and reduced preload—are harmful and must be avoided to prevent hemodynamic collapse. 4

The following interventions worsen LVOT obstruction and are contraindicated:

• Positive inotropes (dobutamine, epinephrine, dopamine): Increase contractility and worsen obstruction 4, 5
• Tachycardia: Reduces diastolic filling time and worsens obstruction 4, 6
• Hypovolemia/reduced preload: Decreases ventricular volume and worsens obstruction 4, 7
• Hypotension/reduced afterload: Increases pressure gradient across LVOT 4, 5
• Excessive diuresis: Creates hypovolemia and worsens obstruction 4

Preoperative Management

Continue all negative inotropic agents (beta-blockers and/or non-dihydropyridine calcium channel blockers) without interruption throughout the perioperative period. 4

Key preoperative considerations:

• Assess LVOT gradient severity: Echocardiography is the primary diagnostic tool to quantify resting LVOT gradients and identify SAM of the mitral valve 2, 8
• Evaluate for cardiac myosin inhibitors: Patients may be on mavacamten (FDA-approved) or aficamten, which decrease cardiac contractility and reduce LVOT obstruction 9, 8
• Risk stratification: Assess for sudden cardiac death risk factors and presence of implantable cardioverter-defibrillator 9
• Identify atrial fibrillation: These patients require anticoagulation regardless of CHADS2-VASc score due to elevated stroke risk 9

Intraoperative Management Algorithm

When hypotension develops, prioritize aggressive intravenous fluid administration first, followed by pure alpha-agonists (phenylephrine or vasopressin) rather than beta-agonists which catastrophically worsen LVOT obstruction. 4

Specific intraoperative strategies:

• Maintain adequate preload: Aggressive fluid administration to ensure ventricular filling 4, 6
• Preserve sinus rhythm: Atrial contraction contributes significantly to ventricular filling in these non-compliant ventricles 4
• Control heart rate: Avoid tachycardia to ensure adequate diastolic filling time 4, 5
• Maintain afterload: Use pure alpha-agonists (phenylephrine, vasopressin) for hypotension, never mixed alpha-beta agonists 4
• Consider invasive monitoring: Arterial line and central venous pressure monitoring may be beneficial for real-time hemodynamic assessment 4, 6
• Intraoperative echocardiography: Transesophageal echocardiography should be considered in hemodynamically unstable patients to evaluate LVOT obstruction severity 4
• Intravenous beta-blockade: In selected cases of refractory hypotension from severe LVOT obstruction, IV beta-blockers may be necessary to reduce myocardial contractility and relieve obstruction 4

Postoperative Management

Minimize sympathetic response in the postoperative period through adequate analgesia and continuation of negative inotropic medications. 6

Critical postoperative considerations:

• Pain control: Inadequate analgesia triggers sympathetic surge, tachycardia, and worsened obstruction 6
• Volume status: Maintain euvolemia; avoid excessive diuresis 4
• Continue home medications: Resume beta-blockers and calcium channel blockers immediately 4

Common Pitfalls and Caveats

Major perioperative complications (cardiac arrest, refractory shock) can occur unexpectedly and are not always correlated with baseline HOCM severity, making vigilance essential even in seemingly mild cases. 10

Critical warnings:

• Undiagnosed HOCM: This is the most common genetic cardiovascular disease (1 in 500 people), so anesthesiologists may encounter undiagnosed cases during routine preoperative evaluation 4, 5
• Deceptive presentation: Patients may be asymptomatic at rest but decompensate catastrophically with anesthesia-induced hemodynamic changes 4, 7
• Reflex responses backfire: Standard responses to hypotension (inotropes, reduced fluids) are catastrophic in HOCM 5, 6
• Neuraxial anesthesia risks: Spinal/epidural anesthesia causes sympathectomy with reduced preload and afterload, potentially worsening obstruction; however, careful titration with adequate preloading may be feasible 6

Special Populations

Obstetric patients with HOCM require particularly careful management of neuraxial anesthesia with meticulous attention to preload maintenance and avoidance of sympathectomy-induced hypotension. 6

Pediatric patients with HOCM have different risk stratification criteria than adults, with risk factors carrying different weights and requiring age-specific and body size-adjusted approaches. 9